MedTrace Logo

Goal-Directed Fluid Therapy for Patients Undergoing Oro-Maxillofacial Surgery

NCT03086694 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2024-06-21

No results posted yet for this study

Summary

Orthognathic surgery, one kind of Oro-maxillofacial surgery, is a complicate surgery that undergoes several hours with nasotracheal intubation general anesthesia. To limit blood loss during operation, the patients are often under intentional hypotension. However, the intentional hypotension may confuse with hypovolemic induced low blood pressure. The hypothesis is using flotrac (to measure stroke volume variation) to keep the patients hemodynamics stable under Tridil and propofol infusion and avoid over-infusion of crystalloid or colloid and prevent hypovolemia induced postoperative nausea and vomiting.

Conditions

  • Blood Pressure, Low

Sponsors & Collaborators

  • Kaohsiung Medical University Chung-Ho Memorial Hospital

    lead OTHER

Principal Investigators

  • kuang I Cheng, MD, PhD · Department of Anesthesiology, Kaohsiung Medical University Chung-Ho Memorial Hospital

Eligibility

Min Age
20 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-04-05
Primary Completion
2019-08-25
Completion
2019-08-31

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03086694 on ClinicalTrials.gov